Prognostic variables in Greek patients with stage II breast cancer: A Hellenic Cooperative Oncology Group Study
dc.contributor.author | Fountzilas, George | en |
dc.contributor.author | Vasilaros, S. | en |
dc.contributor.author | Koukouras, D. | en |
dc.contributor.author | Malamos, N. | en |
dc.contributor.author | Pectasides, Dimitrios | en |
dc.contributor.author | Adamou, A. | en |
dc.contributor.author | Nenopoulou, E. | en |
dc.contributor.author | Kiriakou, K. | en |
dc.contributor.author | Zouvani, I. | en |
dc.contributor.author | Katsohis, C. | en |
dc.contributor.author | Kappas, A. M. | en |
dc.contributor.author | Skopa, C. | en |
dc.contributor.author | Semoglou, C. | en |
dc.contributor.author | Fahantidis, E. | en |
dc.contributor.author | Konstantaras, C. | en |
dc.contributor.author | Vasilaki, E. | en |
dc.contributor.author | Economopoulos, T. | en |
dc.contributor.author | Bacoyiannis, Charalambos | en |
dc.contributor.author | Bafaloukos, Dimitrios | en |
dc.contributor.author | Razi, E. D. | en |
dc.contributor.author | Polichrnis, A. | en |
dc.contributor.author | Androulakis, G. | en |
dc.contributor.author | Papaioannou, T. | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Skarlos, Dimosthenis V. | en |
dc.contributor.author | Kosmidis, Paraskevas A. | en |
dc.creator | Fountzilas, George | en |
dc.creator | Vasilaros, S. | en |
dc.creator | Koukouras, D. | en |
dc.creator | Malamos, N. | en |
dc.creator | Pectasides, Dimitrios | en |
dc.creator | Adamou, A. | en |
dc.creator | Nenopoulou, E. | en |
dc.creator | Kiriakou, K. | en |
dc.creator | Zouvani, I. | en |
dc.creator | Katsohis, C. | en |
dc.creator | Kappas, A. M. | en |
dc.creator | Skopa, C. | en |
dc.creator | Semoglou, C. | en |
dc.creator | Fahantidis, E. | en |
dc.creator | Konstantaras, C. | en |
dc.creator | Vasilaki, E. | en |
dc.creator | Economopoulos, T. | en |
dc.creator | Bacoyiannis, Charalambos | en |
dc.creator | Bafaloukos, Dimitrios | en |
dc.creator | Razi, E. D. | en |
dc.creator | Polichrnis, A. | en |
dc.creator | Androulakis, G. | en |
dc.creator | Papaioannou, T. | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Skarlos, Dimosthenis V. | en |
dc.creator | Kosmidis, Paraskevas A. | en |
dc.date.accessioned | 2018-06-22T09:53:08Z | |
dc.date.available | 2018-06-22T09:53:08Z | |
dc.date.issued | 1997 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41681 | |
dc.description.abstract | The independent effects of several patient, tumor and treatment-related prognostic factors on relapse-free survival (RFS) and overall survival (OS) were assessed by Cox multivariate regression analysis in 988 Greek patients with stage II breast cancer. At a median follow-up time of 83 (range 3.3-131+) months and after the evaluation of all patients together, the number of positive axillary nodes (p < 0.0001), tumor size (p = 0.0024) and tumor grade (p = 0.0008) were identified as significant prognostic factors for RFS. Also, the number of positive nodes (p < 0.0001), tumor size (p = 0.0002) and ER status (p = 0.0001) were found to be significant for OS. These short-term prognostic variables are similar to those reported for this group of patients in other European countries and in the USA. | en |
dc.language.iso | eng | en |
dc.source | Anticancer Research | en |
dc.subject | Regression analysis | en |
dc.subject | Article | en |
dc.subject | Human | en |
dc.subject | 80 and over | en |
dc.subject | Aged | en |
dc.subject | Humans | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Breast neoplasms | en |
dc.subject | Female | en |
dc.subject | Major clinical study | en |
dc.subject | Middle aged | en |
dc.subject | Cancer survival | en |
dc.subject | Chemotherapy | en |
dc.subject | Follow up | en |
dc.subject | Neoplasm staging | en |
dc.subject | Priority journal | en |
dc.subject | Prognosis | en |
dc.subject | Retrospective studies | en |
dc.subject | Tumor volume | en |
dc.subject | Recurrence | en |
dc.subject | Antineoplastic combined chemotherapy protocols | en |
dc.subject | Disease-free survival | en |
dc.subject | Cancer staging | en |
dc.subject | Survival rate | en |
dc.subject | Adjuvant | en |
dc.subject | Lymphatic metastasis | en |
dc.subject | Receptors | en |
dc.subject | Axillary lymph node | en |
dc.subject | Breast cancer | en |
dc.subject | Cancer grading | en |
dc.subject | Estrogen receptor | en |
dc.subject | Lymph node metastasis | en |
dc.subject | Prognostic factors | en |
dc.subject | Combined modality therapy | en |
dc.subject | Greece | en |
dc.subject | Multivariate analysis | en |
dc.subject | Tamoxifen | en |
dc.subject | Estrogen | en |
dc.subject | Europe | en |
dc.subject | Medical records | en |
dc.subject | Menopause | en |
dc.subject | United states | en |
dc.title | Prognostic variables in Greek patients with stage II breast cancer: A Hellenic Cooperative Oncology Group Study | en |
dc.type | info:eu-repo/semantics/article | |
dc.description.volume | 17 | |
dc.description.issue | 6 D | en |
dc.description.startingpage | 4681 | |
dc.description.endingpage | 4689 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.gnosis.orcid | 0000-0002-2195-9961 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |